IDiyas

For the Inventor, By the Inventor

San Diego, CA, United States of America

Trovagene, Inc.


USPTO Granted Patents = 13



Trademarks = 5

Forward Citations = 245

Loading Chart...
Loading Chart...

33 inventors (with patents filed for the assignee):

goldMedal Samuil R Umansky (10 out of 20 patents)

silverMedal Hovsep S Melkonyan (10 out of 11 patents)

bronzeMedal Angela Cannas (4 out of 4 patents)

4.  Louis David Tomei (4 out of 4 patents)

5.  Brunangelo Falini (2 out of 9 patents)

6.  Erik Meyer (2 out of 2 patents)

7.  William John Feaver (2 out of 2 patents)

8.  Zhenghan M Xin (2 out of 2 patents)

9.  Raul Rabadan (1 out of 8 patents)

10.  Cristina Mecucci (1 out of 5 patents)

11.  Eugene M Shekhtman (1 out of 1 patent)

12.  Jason Poole (1 out of 1 patent)

13.  Saege Handcock (1 out of 1 patent)

14.  Karena Kosco (1 out of 1 patent)

15.  Vlada Melnikova (1 out of 1 patent)


13 patents:

1. 9909118 - Compositions, methods and kits for isolating nucleic acids from body fluids using anion exchange media (2018-03-06),
2. 9816148 - Amplification and sequencing of transrenal nucleic acids (2017-11-14),
3. 9725767 - Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof (2017-08-08),
4. 9725755 - Synthesis and enrichment of nucleic acid sequences (2017-08-08),
5. 9453265 - Method for detection of high risk human papillomavirus (2016-09-27),
6. 9222137 - Method for monitoring minimal residual hairy cell leukemia (2015-12-29),
7. 9163229 - Compositions, methods and kits for isolating nucleic acids from body fluids using anion exchange media (2015-10-20),
8. 8642261 - Genetic marker for detection of human papillomavirus (2014-02-04),
9. 8486626 - Methods of detecting cell-free miRNA in urine and blood (2013-07-16),
10. 8383335 - Method for diagnosis and monitoring of viral infection by analysis of viral transrenal nucleic acids in urine (2013-02-26),
11. 7973154 - Kits for diagnosis and monitoring of viral infection by analysis of viral transrenal nucleic acids in urine (2011-07-05),
12. 7914982 - Methods for detecting pathogen specific nucleic acids in urine (2011-03-29),
13. 7803929 - Kits for diagnosis and monitoring of pathogenic infection by analysis of cell-free pathogenic nucleic acids in urine (2010-09-28),
Trovagene, Inc. is a precision cancer monitoring company. They focus on the development and commercialization of molecular diagnostic technologies to detect and monitor various cancers. Their non-invasive tests utilize urine or blood samples to provide actionable information for oncologists and patients. With their proprietary technology, Trovagene aims to improve cancer detection, treatment decisions, and patient outcomes.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

13 Patents

#391 in San Diego, CA

#5,472 in California

#23,099 in US

#43,615 in the World

...
San Diego, CA, United States of America

Trovagene, Inc.

Forward Citations = 245

33 inventors:

goldMedal Samuil R Umansky (10 out of 20 patents)

silverMedal Hovsep S Melkonyan (10 out of 11 patents)

bronzeMedal Angela Cannas (4 out of 4 patents)

4.  Louis David Tomei (4 out of 4 patents)

5.  Brunangelo Falini (2 out of 9 patents)

Please report any incorrect information to support@idiyas.com
Loading…